- Home
- CM vs BDX Comparison
CM vs BDX Comparison
Compare CM & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CM
- BDX
- Stock Information
- Founded
- CM 1867
- BDX 1897
- Country
- CM Canada
- BDX United States
- Employees
- CM N/A
- BDX N/A
- Industry
- CM
- BDX Medical/Dental Instruments
- Sector
- CM
- BDX Health Care
- Exchange
- CM Nasdaq
- BDX Nasdaq
- Market Cap
- CM 58.7B
- BDX 64.5B
- IPO Year
- CM N/A
- BDX 1962
- Fundamental
- Price
- CM $60.84
- BDX $227.48
- Analyst Decision
- CM Buy
- BDX Strong Buy
- Analyst Count
- CM 2
- BDX 7
- Target Price
- CM $92.00
- BDX $278.29
- AVG Volume (30 Days)
- CM 840.7K
- BDX 2.1M
- Earning Date
- CM 02-27-2025
- BDX 02-05-2025
- Dividend Yield
- CM 4.40%
- BDX 1.83%
- EPS Growth
- CM 40.81
- BDX 41.25
- EPS
- CM 5.22
- BDX 5.94
- Revenue
- CM $16,939,361,324.00
- BDX $20,640,000,000.00
- Revenue This Year
- CM N/A
- BDX $9.97
- Revenue Next Year
- CM $5.37
- BDX $4.84
- P/E Ratio
- CM $11.68
- BDX $38.28
- Revenue Growth
- CM 10.71
- BDX 5.89
- 52 Week Low
- CM $46.11
- BDX $218.75
- 52 Week High
- CM $67.45
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- CM 38.23
- BDX 40.90
- Support Level
- CM $60.86
- BDX $221.71
- Resistance Level
- CM $62.43
- BDX $227.45
- Average True Range (ATR)
- CM 0.96
- BDX 4.51
- MACD
- CM -0.03
- BDX -1.30
- Stochastic Oscillator
- CM 64.19
- BDX 19.06
About CM Canadian Imperial Bank of Commerce
Canadian Imperial Bank of Commerce is Canada's fifth-largest bank with around CAD 1 trillion in assets. It operates four business segments: Canadian retail and business banking, Canadian commercial banking and wealth management, US commercial banking and wealth management, and capital markets. It serves approximately 14 million personal banking and business customers, primarily in Canada and the US.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.